Multicentered masked placebo-controlled phase 2 clinical study of an extended duration transdermal buprenorphine solution for postoperative pain in cats.

Autor: Clark TP; Nexcyon Pharmaceuticals, Inc., Madison, Wisconsin, USA., Linton DD; Nexcyon Pharmaceuticals, Inc., Madison, Wisconsin, USA.; Deborah D. Linton, DL Veterinary Consulting, LLC, Rotonda West, Florida, USA., Freise KJ; Nexcyon Pharmaceuticals, Inc., Madison, Wisconsin, USA.; Kevin J. Freise, AbbVie Inc., North Chicago, Illinois, USA., Lin TL; Nexcyon Pharmaceuticals, Inc., Madison, Wisconsin, USA.; Ting-Li Lin, Briostat, LLC, Madison, Wisconsin, USA.
Jazyk: angličtina
Zdroj: Journal of veterinary pharmacology and therapeutics [J Vet Pharmacol Ther] 2022 Jul; Vol. 45 Suppl 1, pp. S40-S51.
DOI: 10.1111/jvp.13059
Abstrakt: A prospective, double-masked, placebo-controlled, multicentered phase 2 clinical study was conducted to select the transdermal buprenorphine solution (TBS) dosage for the control of postoperative pain in cats. One-hundred fifteen (115) cats were randomized to a single topical dose of placebo solution, low-TBS dosage (1.91-2.07 mg/kg) or high-TBS dosage (4.27-4.88 mg/kg) prior to surgical reproductive sterilization in conjunction with forelimb onychectomy. The low- and high-TBS doses were applied 2-4 and 1-2 hours prior to surgery. Interactive pain assessments and physiological variables were quantified through 96 hours post-anesthetic recovery and rescue analgesia was administered any time that analgesia was considered inadequate. Cats requiring rescue analgesia were considered treatment failures. The estimated overall treatment success rates from generalized linear mixed effects model analysis were 0.10 (95% CI: [0.02-0.36]), 0.56 (95% CI: [0.25-0.83]), 0.71 (95% CI: [0.38-0.91]) in the placebo-, low-, and high-TBS dose groups, respectively. Success rates for both TBS treatment groups were superior to placebo. Adverse events were infrequent in all treatment groups although the postoperative body temperatures over the duration of the study were on average 0.31 (95% CI: [0.08-0.55]) and 0.30 (95% CI: [0.05-0.53]) °C higher in low- and high-TBS dose cats, respectively, compared to placebo. It is concluded that both the low- and high-TBS dosages were safe and effective. The high-TBS dosage resulted in a greater proportion of treatment successes over 96 h, had a more acceptable preoperative application time of 1-2 h prior to surgery, and was therefore selected for further study.
(© 2022 John Wiley & Sons Ltd.)
Databáze: MEDLINE
Externí odkaz: